| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Financial Officer
1 company
Reents Scott T is an EVP, Chief Financial Officer at AbbVie Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $2.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | ABBV Abbvie Inc. | EVP, Chief Financial Officer | Sell | 17,644 | $212.34 | $3,746,526.96 | -60.4% | -9.1% | +3.7% | |
| Feb 23, 2024 | ABBV Abbvie Inc. | EVP, Chief Financial Officer | Sale+OE | 14,140 | $177.44 | $2,509,001.60 | -34.3% | -11.1% | +13.5% | |
| Mar 1, 2023 | ABBV Abbvie Inc. | EVP, Chief Financial Officer | Sell | 15,942 | $153.08 | $2,440,354.52 | -86.6% | -12.1% | +13.4% |